Dual-Modal Cellular Nanoparticles for Continuous Neurotoxin Detoxification
Source abstract
Abstract
Neurotoxins are known for their extreme lethality. However, due to their enormous diversity, effective and broad-spectrum countermeasures are lacking. This study presents a dual-modal cellular nanoparticle (CNP) formulation engineered for continuous neurotoxin neutralization. The formulation involves encapsulating the metabolic enzyme N -sulfotransferase (SxtN) into metal–organic framework (MOF) nanoparticle cores and coating them with a natural neuronal membrane, termed “Neuron-MOF/SxtN-NPs”. The resulting nanoparticles combine membrane-enabled broad-spectrum neurotoxin neutralization with enzyme payload-enabled continuous neurotoxin neutralization. The studies confirm the protection of the enzyme payload by the MOF core and validate the continuous neutralization of saxitoxin (STX). In vivo studies conducted using a mouse model of STX intoxication reveal markedly improved survival rates compared with control groups. Furthermore, acute toxicity assessments show no adverse effects associated with the administration of Neuron-MOF/SxtN-NPs in healthy mice. Overall, Neuron-MOF/SxtN-NPs represent a unique biomimetic nanomedicine platform poised to effectively neutralize neurotoxins, marking an important advancement in the field of countermeasure nanomedicine.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · Botulinum Toxin and Related Neurological Disorders · Neurological disorders and treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, La Jolla, California 92093, United States
Funding
Defense Threat Reduction Agency
References (37)
Show source-provided references
1. 10.1038/nrmicro329510.1038/nrmicro3295 ↗
2. 10.1002/anie.20130823510.1002/anie.201308235 ↗
3. 10.1111/1469-0691.1269910.1111/1469-0691.12699 ↗
4. 10.3389/fbioe.2022.86039010.3389/fbioe.2022.860390 ↗
5. 10.3390/toxins1006023110.3390/toxins10060231 ↗
6. 10.1016/j.jtauto.2020.10007610.1016/j.jtauto.2020.100076 ↗
7. 10.1002/jnr.2117110.1002/jnr.21171 ↗
8. 10.1124/jpet.123.00204010.1124/jpet.123.002040 ↗
9. 10.3390/molecules1601020210.3390/molecules16010202 ↗
10. 10.1016/j.apsb.2020.09.00510.1016/j.apsb.2020.09.005 ↗
11. 10.3390/molecules2418327610.3390/molecules24183276 ↗
12. 10.1056/NEJMra210522810.1056/NEJMra2105228 ↗
13. 10.1056/NEJMra01347710.1056/NEJMra013477 ↗
14. 10.3389/fimmu.2021.66832810.3389/fimmu.2021.668328 ↗
15. 10.1369/jhc.2008.95210110.1369/jhc.2008.952101 ↗
16. 10.1002/adma.20170675910.1002/adma.201706759 ↗
17. 10.1002/adma.20210771910.1002/adma.202107719 ↗
18. 10.34133/bmef.001810.34133/bmef.0018 ↗
19. 10.1021/acsnano.2c0831910.1021/acsnano.2c08319 ↗
20. 10.1002/smll.20230963510.1002/smll.202309635 ↗
21. 10.1021/acschembio.9b0012310.1021/acschembio.9b00123 ↗
22. 10.3390/toxins1205034410.3390/toxins12050344 ↗
23. 10.1021/acs.nanolett.0c0165410.1021/acs.nanolett.0c01654 ↗
24. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
25. 10.1073/pnas.171426711410.1073/pnas.1714267114 ↗
26. 10.1038/nature1537310.1038/nature15373 ↗
27. 10.1038/nprot.2015.13110.1038/nprot.2015.131 ↗
28. 10.1016/j.celrep.2021.10893010.1016/j.celrep.2021.108930 ↗
29. 10.1146/annurev.ne.10.030187.00132110.1146/annurev.ne.10.030187.001321 ↗
30. 10.1016/S0006-291X(02)03002-410.1016/S0006-291X(02)03002-4 ↗
31. 10.1371/journal.pone.021375110.1371/journal.pone.0213751 ↗
32. 10.1002/cpz1.6410.1002/cpz1.64 ↗
33. 10.1016/j.toxicon.2016.05.01210.1016/j.toxicon.2016.05.012 ↗
34. 10.1021/np401097n10.1021/np401097n ↗
35. 10.1007/s00216-012-5944-410.1007/s00216-012-5944-4 ↗
36. 10.1021/acs.biochem.0c0034310.1021/acs.biochem.0c00343 ↗
37. 10.1038/s41467-024-44814-110.1038/s41467-024-44814-1 ↗